Published in J Vasc Surg on June 01, 2004
Intracranial and abdominal aortic aneurysms: similarities, differences, and need for a new class of computational models. Annu Rev Biomed Eng (2008) 2.00
Biomechanical and microstructural properties of common carotid arteries from fibulin-5 null mice. Ann Biomed Eng (2010) 1.57
Mechanics, mechanobiology, and modeling of human abdominal aorta and aneurysms. J Biomech (2011) 1.43
Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol (2009) 1.15
Quantitative assessment of abdominal aortic aneurysm geometry. Ann Biomed Eng (2010) 1.08
Diagnosis and monitoring of abdominal aortic aneurysm: current status and future prospects. Curr Probl Cardiol (2010) 1.03
Parametric study of effects of collagen turnover on the natural history of abdominal aortic aneurysms. Proc Math Phys Eng Sci (2013) 1.02
Analysis and computer program for rupture-risk prediction of abdominal aortic aneurysms. Biomed Eng Online (2006) 1.01
Quantification of particle residence time in abdominal aortic aneurysms using magnetic resonance imaging and computational fluid dynamics. Ann Biomed Eng (2010) 0.98
A framework for the automatic generation of surface topologies for abdominal aortic aneurysm models. Ann Biomed Eng (2010) 0.97
The role of geometric and biomechanical factors in abdominal aortic aneurysm rupture risk assessment. Ann Biomed Eng (2013) 0.95
Relative importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in men and women. J Vasc Surg (2013) 0.92
What is the relationship between ¹⁸F-FDG aortic aneurysm uptake on PET/CT and future growth rate? Eur J Nucl Med Mol Imaging (2011) 0.91
Predictive biomechanical analysis of ascending aortic aneurysm rupture potential. Acta Biomater (2013) 0.83
Mechanical instability of normal and aneurysmal arteries. J Biomech (2014) 0.81
Rupture signs on computed tomography, treatment, and outcome of abdominal aortic aneurysms. Insights Imaging (2014) 0.80
Can local secretion of prostaglandin E2, thromboxane B2, and interleukin-6 play a role in ruptured abdominal aortic aneurysm? World J Surg (2008) 0.79
(18)F-FDG PET scanning of abdominal aortic aneurysms and correlation with molecular characteristics: a systematic review. EJNMMI Res (2015) 0.78
Patient-specific finite element analysis of ascending aorta aneurysms. Am J Physiol Heart Circ Physiol (2015) 0.78
Evolving anisotropy and degree of elastolytic insult in abdominal aortic aneurysms: potential clinical relevance? J Biomech (2014) 0.78
Ruptured abdominal aortic aneurysm-epidemiology, predisposing factors, and biology. Langenbecks Arch Surg (2016) 0.76
Robust infrarenal aortic aneurysm lumen centerline detection for rupture status classification. Med Eng Phys (2013) 0.76
The - Not So - Solid 5.5 cm Threshold for Abdominal Aortic Aneurysm Repair: Facts, Misinterpretations, and Future Directions. Front Surg (2016) 0.75
Indicators of survival after open repair of ruptured abdominal aortic aneurysms and an index for predicting aneurysmal rupture potential. Ann Vasc Dis (2011) 0.75
A Tender Pulsatile Epigastric Mass is NOT Always an Abdominal Aortic Aneurysm: A Case Report and Review of Literature. J Radiol Case Rep (2010) 0.75
Interaction of expanding abdominal aortic aneurysm with surrounding tissue: Retrospective CT image studies. J Nat Sci (2015) 0.75
Monitoring the biological activity of abdominal aortic aneurysms Beyond Ultrasound. Heart (2016) 0.75
Effects of anatomical characteristics as factors in abdominal aortic aneurysm rupture: CT aortography analysis. Medicine (Baltimore) (2017) 0.75
A machine learning approach to investigate the relationship between shape features and numerically predicted risk of ascending aortic aneurysm. Biomech Model Mechanobiol (2017) 0.75
Role of molecular imaging with positron emission tomographic in aortic aneurysms. J Thorac Dis (2017) 0.75
Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg (2010) 3.45
Risk-adjusted 30-day outcomes of carotid stenting and endarterectomy: results from the SVS Vascular Registry. J Vasc Surg (2008) 3.06
Derivation and validation of a practical risk score for prediction of mortality after open repair of ruptured abdominal aortic aneurysms in a US regional cohort and comparison to existing scoring systems. J Vasc Surg (2012) 2.78
The effect of postoperative myocardial ischemia on long-term survival after vascular surgery. J Vasc Surg (2013) 2.72
Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg (2003) 2.71
National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg (2009) 2.55
Factors associated with stroke or death after carotid endarterectomy in Northern New England. J Vasc Surg (2008) 2.22
Regional variation in carotid artery stenting and endarterectomy in the Medicare population. Circ Cardiovasc Qual Outcomes (2009) 2.21
Optimal selection of asymptomatic patients for carotid endarterectomy based on predicted 5-year survival. J Vasc Surg (2013) 2.16
Decrease in total aneurysm-related deaths in the era of endovascular aneurysm repair. J Vasc Surg (2009) 2.16
The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) (2002) 2.10
Thoracic endovascular aneurysm repair, race, and volume in thoracic aneurysm repair. J Vasc Surg (2012) 2.07
Withdrawal of article by the FDA after objection from Medtronic. J Vasc Surg (2004) 2.04
Intraoperative use of dextran is associated with cardiac complications after carotid endarterectomy. J Vasc Surg (2013) 2.02
Thirty-day mortality and late survival with reinterventions and readmissions after open and endovascular aortic aneurysm repair in Medicare beneficiaries. J Vasc Surg (2010) 2.02
Survival after open versus endovascular thoracic aortic aneurysm repair in an observational study of the Medicare population. Circulation (2011) 2.00
Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet (2003) 1.98
Screening for abdominal aortic aneurysm: a consensus statement. J Vasc Surg (2004) 1.96
Regulation of vascular smooth muscle cell differentiation. J Vasc Surg (2007) 1.92
In vivo analysis of mechanical wall stress and abdominal aortic aneurysm rupture risk. J Vasc Surg (2002) 1.92
Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg (2009) 1.86
Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg (2009) 1.81
Infliximab in the treatment of refractory posterior uveitis. Ophthalmology (2003) 1.75
Stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria. J Vasc Surg (2010) 1.73
Endovascular abdominal aortic aneurysm repair: long-term outcome measures in patients at high-risk for open surgery. J Vasc Surg (2006) 1.68
Population-based outcomes following endovascular and open repair of ruptured abdominal aortic aneurysms. J Endovasc Ther (2009) 1.68
Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg (2012) 1.65
Impact of screening versus symptomatic measurement of deep vein thrombosis in a national quality improvement registry. J Vasc Surg (2012) 1.63
A regional quality improvement effort to increase beta blocker administration before vascular surgery. J Vasc Surg (2011) 1.61
Accuracy of administrative data versus clinical data to evaluate carotid endarterectomy and carotid stenting. J Vasc Surg (2013) 1.59
The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol (2003) 1.57
Carotid endarterectomy in asymptomatic patients with limited life expectancy. Stroke (2012) 1.54
Outcomes and practice patterns in patients undergoing lower extremity bypass. J Vasc Surg (2012) 1.53
Impact of practice patterns in shunt use during carotid endarterectomy with contralateral carotid occlusion. J Vasc Surg (2011) 1.53
Heterogeneity among patients with tumor necrosis factor receptor-associated periodic syndrome phenotypes. Arthritis Rheum (2003) 1.51
Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg (2008) 1.50
Risk prediction for perioperative mortality of endovascular vs open repair of abdominal aortic aneurysms using the Medicare population. J Vasc Surg (2009) 1.46
Carotid artery stenting and patient outcomes: the CABANA surveillance study. Catheter Cardiovasc Interv (2014) 1.45
The impact of endovascular procedures on fellowship training in lower extremity revascularization. J Vasc Surg (2012) 1.44
Predicting 1-year mortality after elective abdominal aortic aneurysm repair. J Vasc Surg (2009) 1.43
Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling. J Biol Chem (2007) 1.35
The Vascular Study Group of New England Cardiac Risk Index (VSG-CRI) predicts cardiac complications more accurately than the Revised Cardiac Risk Index in vascular surgery patients. J Vasc Surg (2010) 1.34
Isolated dissection of the abdominal aorta: clinical presentation and therapeutic options. J Vasc Surg (2002) 1.28
Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol (2006) 1.26
Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther (2004) 1.23
Identification of RING finger protein 4 (RNF4) as a modulator of DNA demethylation through a functional genomics screen. Proc Natl Acad Sci U S A (2010) 1.22
Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour. Immunology (2004) 1.22
National trends and regional variation of open and endovascular repair of thoracic and thoracoabdominal aneurysms in contemporary practice. J Vasc Surg (2011) 1.22
Acceleration of cardiovascular disease by a dysfunctional prostacyclin receptor mutation: potential implications for cyclooxygenase-2 inhibition. Circ Res (2008) 1.17
Gender differences in abdominal aortic aneurysm presentation, repair, and mortality in the Vascular Study Group of New England. J Vasc Surg (2013) 1.17
Validation of the Society for Vascular Surgery's objective performance goals for critical limb ischemia in everyday vascular surgery practice. J Vasc Surg (2011) 1.16
Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function. Arthritis Rheum (2006) 1.16
Risk of late-onset adhesions and incisional hernia repairs after surgery. J Am Coll Surg (2013) 1.16
Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia. J Vasc Surg (2007) 1.15
Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg (2011) 1.13
The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am J Physiol Heart Circ Physiol (2006) 1.12
Body mass index: surgical site infections and mortality after lower extremity bypass from the National Surgical Quality Improvement Program 2005-2007. Ann Vasc Surg (2009) 1.12
Vascular injury during anterior exposure of the spine. J Vasc Surg (2008) 1.12
Preoperative pulse pressure and major perioperative adverse cardiovascular outcomes after lower extremity vascular bypass surgery. Anesth Analg (2011) 1.09
Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Ann Vasc Surg (2009) 1.09
Failure to achieve clinical improvement despite graft patency in patients undergoing infrainguinal lower extremity bypass for critical limb ischemia. J Vasc Surg (2010) 1.08
Mesenteric stenting for chronic mesenteric ischemia. J Vasc Surg (2005) 1.08
Restenosis after carotid endarterectomy in a multicenter regional registry. J Vasc Surg (2010) 1.06
Shedding of mutant tumor necrosis factor receptor superfamily 1A associated with tumor necrosis factor receptor-associated periodic syndrome: differences between cell types. Arthritis Rheum (2004) 1.06
Regulation of Hex gene expression and initial stages of avian hepatogenesis by Bmp and Fgf signaling. Dev Biol (2004) 1.05
Ultrasound-guided percutaneous endovascular aneurysm repair success is predicted by access vessel diameter. J Vasc Surg (2012) 1.05
Adiponectin induces vascular smooth muscle cell differentiation via repression of mammalian target of rapamycin complex 1 and FoxO4. Arterioscler Thromb Vasc Biol (2011) 1.05
Protamine reduces bleeding complications associated with carotid endarterectomy without increasing the risk of stroke. J Vasc Surg (2010) 1.04
Volume-outcome relationships and abdominal aortic aneurysm repair. Circulation (2010) 1.04
Choice of vascular surgery as a specialty: survey of vascular surgery residents, general surgery chief residents, and medical students at hospitals with vascular surgery training programs. J Vasc Surg (2004) 1.03
Outcomes of symptomatic abdominal aortic aneurysm repair. J Vasc Surg (2010) 1.02
Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes. Arthritis Rheum (2007) 1.01
Predicting ambulation status one year after lower extremity bypass. J Vasc Surg (2009) 1.01
Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease. J Vasc Surg (2008) 1.00
Early discharge does not increase readmission or mortality after high-risk vascular surgery. J Vasc Surg (2012) 1.00
Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. J Vasc Surg (2012) 1.00
Neuroprotection during carotid artery stenting using the GORE flow reversal system: 30-day outcomes in the EMPiRE Clinical Study. Catheter Cardiovasc Interv (2010) 1.00
Role of interleukin-6 in a patient with tumor necrosis factor receptor-associated periodic syndrome: assessment of outcomes following treatment with the anti-interleukin-6 receptor monoclonal antibody tocilizumab. Arthritis Rheum (2011) 0.99
Endovascular repair of abdominal aortic aneurysm without preoperative arteriography. J Vasc Surg (2003) 0.99